Introduction {#s1}
============

Aortic arc anomalies (AAA) are rare congenital cardiac anomalies; they represent approx. 1--3% of all cardiovascular anomalies [@pone.0024903-Weinberg1]. In right-sided aortic arches (RAAA) the aorta originates from the left ventricle and takes a rightward turn before its descent through the mediastinum, whereas double-sided aortic arch anomalies (DAAA) are combinations of a right-sided and a left sided aortic arch [@pone.0024903-Marmon1]. This duplication often forms a vascular ring around the trachea and/or oesophagus, which tends to compress these [@pone.0024903-Eichhorn1], [@pone.0024903-HernanzSchulman1], [@pone.0024903-McLaren1]. Likewise, a RAAA, together with the ligamentum arteriosum (the remnant of the ductus arteriosus Botalli) may also cause compression of the mediastinal structures by forming a so called aortic sling. Therefore, both anomalies may cause stridor, cough, dyspnoea, dysphagia and recurrent lower airway infections [@pone.0024903-Turner1], [@pone.0024903-Griffiths1], [@pone.0024903-Bonnard1], [@pone.0024903-Lowe1]. Based on surgical series, DAAA are the most common causes of vascular rings, followed by a right aortic arch with an aberrant left subclavian and left ductal ligament [@pone.0024903-DodgeKhatami1]. According to Bonnard et al. the majority (94%) of symptomatic AAA were successfully treated with surgical repair [@pone.0024903-Bonnard1]. Hence, there is commonly a low threshold for early corrective surgery in these patients.

AAA can be identified by fetal ultrasound as early as 12 weeks gestational age (GA) [@pone.0024903-Zidere1]. The postnatal diagnosis of AAA can be made by echocardiography, barium swallow studies, magnetic resonance imaging (MRI), or computer tomography (CT) [@pone.0024903-Ma1], [@pone.0024903-Humphrey1]. While echocardiography allows sufficient imaging of the great vessels, airway obstruction is either confirmed by indirect imaging studies like barium swallow [@pone.0024903-Burch1], or by CT or MRI, which are associated with either high doses of radiation and/or high costs [@pone.0024903-Turner1]. Therefore, lung function tests (LFT) have been suggested as non-invasive, non-radiating diagnostic tests to diagnose and monitor the progression of airway obstruction in patients with AAA [@pone.0024903-Thomson1]. However, possibly due to lack of systematic investigations, only little data exists on LFT in children with AAA [@pone.0024903-Thomson1], [@pone.0024903-Amirav1].

We hypothesized that lung function testing in the neonatal period allows the identification and monitoring of patients with AAA. We aimed to investigate newborn infants with AAA and to describe the typical LFT findings.

Methods {#s2}
=======

Ethics statement {#s2a}
----------------

Neonatal lung function testing (LFT) was approved by the Charité University Hospital\'s ethics committee (ID 54/92). Written parental consent was obtained before each individual LFT.

Subjects {#s2b}
--------

This was a retrospective study from a large tertiary referral centre for congenital abnormalities (Charité University Medical Centre Berlin). All surviving neonates with a prenatal diagnosis of AAA, born between January 2005 and March 2011, were included in the study. Postnatal management included admission to the neonatal intensive care unit for observation of cardiac or respiratory symptoms and further diagnostic echocardiography.

Protocol {#s2c}
--------

Whenever possible, tests were performed around discharge from the unit. A single operator performed the LFTs in our lung function laboratory. Patients were not investigated if they had symptoms of an active respiratory tract infection (RTI), or had suffered a RTI within 2 weeks prior to the scheduled LFT. Before LFT, body weight was measured with a standard digital scale to the nearest 10 grams (Seca®, Hamburg, Germany), body length from crown to heel was measured by an inelastic tape to the nearest centimetre.

Infants were studied after having received chloral hydrate (50 mg kg^−1^) given orally 30--60 min before LFT. Sleeping infants were measured in supine position with the neck in a neutral position, supported by a neck roll. Three independent lung function tests were used to asses upper airway obstructions: the shape of the flow-volume measured during tidal breathing (TBFVL), the measurement of airway resistance using baby bodyplethysmography and the measurement of forced expiratory flow at functional residual capacity (V′~max~FRC).

TBFVLs were measured using custom made equipment based on the flow-through technique [@pone.0024903-Schmalisch1]. Briefly, the facemask is continuously rinsed thoroughly by a constant background flow, which eliminates apparatus dead space thus allowing long-term measurements. Depending on the variability of the breathing pattern 20--60 consecutive breaths were measured and an averaged breathing loop was calculated as described previously [@pone.0024903-Schmalisch2]. As shown in [Fig. 1](#pone-0024903-g001){ref-type="fig"} upper-airway obstructions cause a horizontal flattening of the inspiratory and/or expiratory limb so that the TBFVL became a rectangular shape, as described by Leonhardt et al. [@pone.0024903-Leonhardt1].

![Consecutively measured tidal breathing flow-volume loops of newborns.\
Loops of a healthy newborn (1A) and loops of an infant with DAAA (1B), which illustrates the characteristic inspiratory and expiratory flow limitations. The left side of the figures show a series of consecutive breathing cycles and the right side the calculated averaged loop (by definition: inspiration shown on lower part of the graph, expiration on the top part of the graph).](pone.0024903.g001){#pone-0024903-g001}

The airway resistance (R~aw~) was measured by baby-bodyplethysmography (Jaeger Master Screen/Babybody, VIASYS, Würzburg, Germany) [@pone.0024903-Bisgaard1]. Upper airway obstructions cause an increase in R~aw~, however, the measured R~aw~ is highly method- and growth-dependent and there are no accepted reference ranges [@pone.0024903-Stocks1].

With the same equipment V′~max~FRC were measured using the rapid thoracic-abdominal compression (RTC) technique, according to international guidelines [@pone.0024903-Sly1]. V′~max~FRC was also expressed in standard deviation scores (Z-scores) based on sex-, age and hight-specific reference values of healthy infants published by Hoo et al. [@pone.0024903-Hoo1].

During the pulmonary function tests, heart rate and oxygen saturation were monitored continuously by pulse oximetry (model N-200; Nellcor, Hayward, California).

Statistical methods {#s2d}
-------------------

Patient\'s characteristics and the results of LFT were described by incidences or median and range. For the comparison between infants with RAAA and DAAA the exact Fischer test or Mann-Whitney rank test was used as appropriate. Regression analysis was used to investigate the relationship between the Z-score of V′~max~FRC and R~aw~. Statistical analysis was performed using Statgraphics Centurion® software (Version 15.0, Statpoint Inc., Herndon, Virginia, USA). A level of statistical significance of p\<0.05 was accepted.

Results {#s3}
=======

Patients {#s3a}
--------

Seventeen patients with AAA (10 RAAA, 7 DAAA) were analysed. The median (range) post conceptional age at LFT was 40.3 (36.6--44.1) weeks and the median body weight was 3400 (2320--4665) grams. There was no statistically significant difference between the infants with RAAA or DAAA at birth or at the time of LFT, as shown in [Table 1](#pone-0024903-t001){ref-type="table"}.

10.1371/journal.pone.0024903.t001

###### Comparison of patient characteristics of infants with right-sided (RAAA) and double-sided aortic arch anomaly (DAAA) (presented as median (range) or n (%)).

![](pone.0024903.t001){#pone-0024903-t001-1}

                                      RAAA n = 10         DAAA n = 7       p-value
  ------------------------------- ------------------- ------------------- ---------
  *At birth*                                                              
  Gestational age (weeks)            38.5 (36--41)        40 (36--41)       0.520
  Birth weight (g)                 3295 (2800--3665)   3420 (2330--4150)    0.435
  Male                                  5 (50%)             2 (29%)         0.622
  *At time of measurement*                                                
  Age (days)                          6.5 (3--22)         9 ( 5--34)        0.202
  Post conceptional age (weeks)    39.4 (36.6--44.1)   40.9 (37.3--44.0)    0.305
  Body weight (g)                  3250 (2605--3780)   3550 (2320--4665)    0.353
  Body length (cm)                    50 (46--55)         53 (44--56)       0.224

Lung function measurements {#s3b}
--------------------------

LFT were performed around the 40^th^ post conceptional week (term). The results are shown in [table 2](#pone-0024903-t002){ref-type="table"}: The TBFVL indicated significantly more expiratory flow limitations in infants with DAAA compared to infants with RAAA. The combination of inspiratory and expiratory flow limitation was only seen in four infants with DAAA. [Figure 1](#pone-0024903-g001){ref-type="fig"} illustrates a characteristic example of a typical TBFVL, as seen in DAAA patients.

10.1371/journal.pone.0024903.t002

###### Comparison of the results of lung function testing in infants with right-sided and double-sided aortic arch anomaly (presented as median (range) or n (%), statistically significant p-values are printed in bold).

![](pone.0024903.t002){#pone-0024903-t002-2}

                                                             RAAA n = 10           DAAA n = 7         p-value
  ----------------------------------------------------- --------------------- --------------------- -----------
  *Shape of the TBFVL*                                                                              
  Inspiratory flow limitation                                  2 (20%)               4 (57%)           0.162
  Expiratory flow limitation                                   3 (30%)               6 (86%)         **0.049**
  Combined inspiratory and expiratory flow limitation          0 (0%)                4 (57%)         **0.015**
  *Measurements of airway resistance*                                                               
  R~aw~ (kPa/L/s)                                         1.58 (0.35--5.9)     3.09 (1.05--12.93)      0.097
  R~aw~ (kPa/L/s) \>2.81 kPa/L/s                               2 (20%)               6 (86%)         **0.015**
  *Measurement of V′~max~FRC*                                                                       
  V′~max~FRC (mL/s)                                        95.5 (19--182)         75 (53--168)         0.435
  Z-Score V′~max~FRC                                     −0.16 (−1.87--1.07)   −0.93 (−1,58--0.77)     0.283

An expiratory flow limitation was associated with a significantly increased R~aw~ ([Fig. 2](#pone-0024903-g002){ref-type="fig"}). However, there were differences in R~aw~ between infants with RAAA and DAAA. As shown in [table 2](#pone-0024903-t002){ref-type="table"}, 6/7 (86%) infants with DAAA had an increased R~aw~ (p = 0.015) above the group median of all infants (2.81 cmH~2~O/L/s).

![Expiratory flow limitation of the TBFVL and its impact on airway resistance (R~aw~ is presented on a logarithmical scale and the horizontal bar represents the median).](pone.0024903.g002){#pone-0024903-g002}

Despite a significant correlation between R~aw~ and the Z-score of V′~max~FRC (r = 0.740, p\<0.001) there were no statistically significant differences in V′~max~FRC and the Z-scores of V′~max~FRC between RAAA and DAAA infants. As shown in [Fig. 3](#pone-0024903-g003){ref-type="fig"}, four (24%) infants (2 RAAA, 2 DAAA) were near or below the 10^th^ percentile of V′~max~FRC, which is indicative for a high risk of airway obstructions.

![Correlation between Z-score of V′~max~FRC and R~aw~ of infants with AAA.](pone.0024903.g003){#pone-0024903-g003}

Discussion {#s4}
==========

The study has shown that most infants with AAA have normal LFT at term. However, infants with DAAA as well as RAAA are at increased risk of airway obstruction, and these infants can clearly be identified by early LFT.

The risk of airway obstruction is higher in infants with DAAA compared to infants with RAAA. Combined in- and expiratory flow limitation (illustrated by the typical rectangular TBFVL, [Fig. 1](#pone-0024903-g001){ref-type="fig"}) was only seen in infants with DAAA. Most DAAA infants showed increased R~aw~ and their median R~aw~ was almost twice that of infants with RAAA, as shown in [Table 2](#pone-0024903-t002){ref-type="table"}.

There is a lack of LFT studies in infants with AAA and this is to date the largest aggregation of early, pre-surgical lung function testing of such infants. Previously, Thomson et al. compared pre- and postoperative LFT in six children with vascular rings, also using a Jaeger Baby-Plethysmograph® [@pone.0024903-Thomson1]: All patients had pathologic LFT and evidence of tracheal compression; four infants had decreased values for FRC [@pone.0024903-Thomson1]. Also, and similar to our study, Amirav et al. found significantly increased R~aw~ and decreased values for V′~max~FRC [@pone.0024903-Amirav1].

To date, the gold standard for confirming the diagnosis of AAA is by contrast CT or MRI [@pone.0024903-Ma1]. Comparative studies of LFT and imaging studies have not yet been performed. Performing LFT in AAA offers the advantage of using a non-invasive method, which spares the patient a high load of radiation (CT) or intensive apparatus and cost generating investigations (MRI/CT). We believe that early LFT can serve as a non-invasive tool for diagnosing the extent of airway compression by the shape of the TBFVL, the elevation in R~aw~ and V′~max~FRC reduction.

The decision for corrective surgery is traditionally based on the patient\'s clinical presentation. However, one patient from our analysis with a preoperative diagnosis of RAAA was intra-operatively found to have DAAA. Interestingly, this patient had a longstanding history of \>3 clinical symptoms related to AAA, including recurrent respiratory infections. The TBFVL at term showed the typical configuration of a DAAA infant. His R~aw~ at term (3.71 cmH~2~O/L/s) was higher than the median found in our RAAA group (1.58 cmH~2~O/L/s) and even higher than that for the DAAA group (3.09 cmH~2~O/L/s). Also, his V′~max~FRC of 64 L/s was well below the median (95.5 L/s) found for RAAA infants.

Three neonatal lung function tests were used in this study. These tests assessed different aspects of airway obstruction. The TBFVL demonstrates flow limitations, which are predictive for airway obstruction [@pone.0024903-Leonhardt1]. However, TBFVL have the disadvantage that they not only reflect lung mechanics but also the patients\' voluntary breathing patterns [@pone.0024903-Schmalisch3]. As for the other tests, R~aw~ primarily describes the conductivity of the upper airways, while V~max~FRC mostly describes small airway conductivity [@pone.0024903-Sly1]. Our study has shown that the combination of these three methods can reliably identify the presence and the degree of airway obstruction in AAA patients.

Our study has several limitations. Firstly, RAAA and DAAA are rare malformations. The small number of patient data in our study limits its statistical power and increases the risk of a type II error. Only a limited number of measurements were available for comparing subgroups. Thus, the absence of significant differences in R~aw~ and V~max~FRC between both patient groups may be due to the low sample size and the high inter subject variability of lung function parameters. Furthermore, to date no age-dependent reference values exist for R~aw~, mainly because these values are highly dependent on the method of measurement and of the infants\' growth [@pone.0024903-Stocks1], [@pone.0024903-Stocks2]. Although we believe to have found a clinically useful interpretation of R~aw~ by using the relationship between R~aw~ and the Z-score of V′~max~FRC, this has not been previously studied and requires further investigation.

In conclusion, and different to previous common belief, we found that both groups of AAA patients (RAAA and DAAA) are at risk for airway obstruction. Early LFT helps to identify and to monitor such infants. Early LFT may support the decision for a surgical intervention even before clinical symptoms arise.
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